Iron chelation therapy in myelodysplastic syndrome - Cui bono?
Tefferi
A
A
Stone
R M
RM
D000368:Aged; D001565:Benzoates / Q000627:therapeutic use*; D015415:Biomarkers; D015913:Chelation Therapy; D000077588:Deferasirox; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D008017:Life Expectancy; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000628:therapy; D065227:Transfusion Reaction; D014230:Triazoles / Q000627:therapeutic use*
D001565:Benzoates; D015415:Biomarkers; D007502:Iron Chelating Agents; D014230:Triazoles; D005293:Ferritins; D007501:Iron; D000077588:Deferasirox